News

RCMI members' Article

📢 Big News! Prof. Wong Man-sau (RCMI Director), Prof. Jerry Yeung (RCMI Associate Director) and Dr. Poon Chui Wa Christina (RCMI member), have published an article in The Voice of St. James Settlement (July 2024, Issue 575) titled "Improving Sarcopenia and Insomnia with Traditional Chinese Medicine and Dietary Therapy".

The 13th Annual Meeting GP-TCM RA🌍💊

The 13th Annual Meeting GP-TCM RA🌍💊 Prof. Simon Lee , RCMI Management Committee member attended the 13th Annual Meeting GP-TCM RA in London, titled One Health – Potential for the Integration of Chinese Medicine, from 24–27 July 2025. The meeting focused on the theme of One Health, exploring the integration of Chinese medicine with modern healthcare systems. The event provided a platform for experts, researchers, and practitioners to discuss collaborative approaches in medical research, education, and clinical practice. This meeting underscores the growing global interest in integrating traditional and conventional medicine, aligning with the One Health initiative, which emphasizes interdisciplinary cooperation for human, animal, and environmental health.

PAIR Education Programm

Join the program from September to December 2025 to stay ahead in the ever-evolving world of science and healthcare! https://polyu.hk/MKTux

Call for Abstract of PPCR 2025

Join the 14th Pan-Pacific Conference on Rehabilitation (PPCR 2025) Innovations in Rehabilitation Sciences: Research, Education & Knowledge Transfer 8-9 Nov 2025 | InnoCentre, Hong Kong Why Attend? 5 world-class plenary speakers Cutting-edge research & advancements Submit abstracts for oral/poster presentations Early-bird & abstract deadline: 15 Aug 2025 Register now: polyu.hk/ridle

PolyU Research Projects Secure RAISe+ Funding, Including Led Project by Prof. Simon Lee

PolyU Research Projects Secure RAISe+ Funding, Including Led Project by Prof. Simon Lee

RCMI delegation visits Northern China

RCMI delegation visits Northern China   Prof. WONG Man-sau, Director of the Research Centre for Chinese Medicine Innovation (RCMI) of The Hong Kong Polytechnic University (PolyU), led a delegation of six members from RCMI on a duty visit to Mainland China from 24 to 28 June, aiming to further expanding PolyU’s partnerships in traditional Chinese medicine (TCM) education and research in the Mainland.   The group travelled to several cities in Northern China, including Baoding and Anguo in Hebei province, and Beijing, and visited several organisations in the healthcare and industry sectors.  These included Baoding Traditional Chinese Medicine Hospital, Jimon Group in Anguo, and Nestlé Research and Development Center in Beijing.  The group engaged in lively discussions with the organisation representatives, exchange views on a wide range of topics related to TCM development such as medicine formulas and effects, Hong Kong’s strengths in research commercialisation, hospital-made medicines, women’s health, TCM education, Chinese medicine-based food product, etc.   RCMI and Baoding TCM Hospital agreed to further strengthen collaboration in upgrading medicinal and food products, transforming hospital-made medicines, and exploring new models of TCM education, research and industry collaboration, with the goal of achieving complementary advantages, resource sharing, coordinated development and mutual benefit.  

RCMI IAB Meeting and Seminar

On the next day (17 June 2025), the Centre held its third International Advisory Board (IAB) Meeting, during which IAB members  recognized the center's achievements and gave valuable recommendations for RCMI’s future development, particularly in strengthening collaborations and partnerships.  Following the meeting was a seminar delivered by Prof. Rudolf BAUER, Professor Emeritus at the Institute of Pharmaceutical Sciences, University of Graz, Austria, who expounded on the hurdles in drug development and regulatory issues of CM-derived medicines. This also provided an engaging platform for the guests to learn about the latest developments and challenges in CM-derived medicines.  

RCMI Retreat 2025 successfully held

The Research Centre for Chinese Medicine Innovation (RCMI) organised its 2025 Retreat at Hotel ICON on 16 June 2025. The Retreat provided a valuable platform on which RCMI members shared their research findings and exchanged views on traditional Chinese medicine (TCM) development. Prof. WONG Man-sau, Director of RCMI, presented an overview of the Centre’s achievements in the past three years. This was followed by keynote presentations by Dr Vincent CHUNG Chi-ho, Commissioner for Chinese Medicine Development, Health Bureau, HKSAR, who shared insights on the landscape of TCM in Hong Kong, and Ms Amylia CHAN, Assistant Director of Knowledge Transfer and Entrepreneurship Office, PolyU, who highlighted PolyU’s expertise in contributing to TCM advances. RCMI members also gave presentations on their funded projects, and the attendees had a group discussion focusing on boosting RCMI’s international recognition and societal impact. A heartfelt thank you to all participants for their valuable contributions and enthusiastic engagement, making the RCMI retreat a resounding success! We appreciate everyone who took part and played a role in its achievement.

Asia Submit 2025

RCMI at ASGH 2025 The Director of the Research Centre of Chinese Medicine Innovation (RCMI) participated in the annual Asia Summit on Global Health (ASGH) 2025, held on 26–27 May at the Hong Kong Convention and Exhibition Centre. This prestigious event brought together global leaders, policymakers, researchers, and industry professionals to discuss the latest trends and opportunities in the health sector. During the summit, Prof. Wong’s research team played an active role, not only attending key sessions and networking events but also exhibiting the Centre’s innovative startup companies. Two RCMI spin-off companies, Wellness Phytoscience and AIM Pharmaceutical, were featured at the exhibition. Both companies showcased their latest research breakthroughs and technological advancements in the field of Chinese medicine and health innovation. Wellness Phytoscience presented its cutting-edge developments in botanical supplements and functional foods, emphasizing evidence-based approaches to wellness and preventive healthcare. AIM Pharmaceutical highlighted its novel drug discovery platforms and recent progress in developing new therapeutic agents derived from traditional Chinese medicine. The participation of RCMI and its spin-off companies at ASGH 2025 underscored the Centre’s commitment to translating research into real-world applications and fostering collaborations with industry partners. The event provided valuable opportunities for knowledge exchange, partnership building, and raising the international profile of RCMI’s research and entrepreneurial achievements.

2025 International Conference on Polysaccharides for Nutraceuticals and Future Foods

RCMI co-organized and DoRCMI actively participated in the 2025 International Conference on Polysaccharides for Nutraceuticals and Future Foods, held from 23 to 25 May 2025. This event brought together leading scientists and professionals from around the world, providing a dynamic platform to share and discuss the latest innovations, research findings, and emerging trends in the field of polysaccharides, with a particular focus on their applications in health, nutrition, and sustainable food systems. Through active engagement in presentations, panel discussions, and networking sessions, DoRCMI contributed to advancing knowledge and fostering collaborations aimed at promoting the development of nutraceuticals and future foods for improved health and sustainability.